Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Vaxil Bio Therapeutics VXL
(Total Views: 1133)
Posted On: 06/24/2019 2:39:30 PM
Post# of 96
Posted By: GaryM
Re: Pussim #38
Pussim,

The FDA seemed to be open to trials that evolve, at least they were under Scott Gottlieb, I would hope that a Phase 2 where the results could be reviewed could evolve into a Phase 3 where the patients added could be in a blind test, but they'd be added to the Phase 2 patients who's outcome up to the start of the Phase 3 portion is known. Such an evolving trial reduces cost and time, and in reality you get the advantage of tracking the Phase 2 patients longer, which should add survival data that otherwise isn't available in making the approval decision.

I suspect the key to the initiation of this trial may be financial, any thoughts about that. Also, do you believe they'll do the Phase 2 multi-nationally, if not, where do you believe they'll conduct the trial.

Gary

(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site